findmyKOL
Clinical trialNCT02614547CompletedPhase 2Interventional

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

SponsorSupernus Pharmaceuticals, Inc.Enrollment21Severe Postpartum Depression
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Sage Investigational Site

    Atlanta, Georgia, United States

  • Sage Investigational Site

    Worcester, Massachusetts, United States

  • Sage Investigational Site

    Chapel Hill, North Carolina, United States

  • Sage Investigational Site

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboSAGE-547
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Dec 2015
Primary completion
22 Jun 2016
Completion
22 Jun 2016
Last update posted
15 Sept 2025
Registered enrollment
21
Registry id
NCT02614547
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.